wehale.life for healthcare professionals

Dear Healthcare Professional,

Welcome to Wehale.life - website about asthma and COPD (chronic obstructive pulmonary disease). This section is intended for healthcare professionals treating people with respiratory conditions. Depending on the country you might have to register to get access.
Choose your local article below - or scroll down to choose your country. Read more about wehale.life content for Healthcare Professionals


Events
en
ERS 2020 - join the virtual congress

ERS 2020 - join the virtual congress

Orion Pharma and Menarini warmly welcome all healthcare professionals to the jointly organized virtual symposium, Successful inhalation therapy in 2020: patients and inhalers in focus. The symposium, chaired by Professor Eric Bateman, is available for all registered ERS participants. Read more and register now

Insights
sv
Single-inhaler combination therapy in bronchial asthma – real-world data from daily clinical practice

Single-inhaler combination therapy in bronchial asthma – real-world data from daily clinical practice

Real-world studies can provide valuable information on patient experience and satisfaction with the inhaler, as well as on clinical efficacy and adherence to inhaled treatment in daily use. Read about the efficacy of combination therapy in bronchial asthma as evaluated in a Polish real-world study.

Insights
pl
Terapia wziewna – ze szczególnym uwzględnieniem steroidów – w okresie pandemii COVID-19

Terapia wziewna – ze szczególnym uwzględnieniem steroidów – w okresie pandemii COVID-19

Insights
es
Cercano al inhalador ideal: fácil y conveniente

Cercano al inhalador ideal: fácil y conveniente

Para cumplir con el concepto de un inhalador "ideal", el dispositivo debe albergar una serie de características entre las que se encuentran ser efectivo, cómodo, versátil y ecológico.

Insights
nl-BE
Inhaler-switch in real-world clinical practice – impact on clinical outcomes and QoL

Inhaler-switch in real-world clinical practice – impact on clinical outcomes and QoL

Real-world studies are essential in comparing different inhalers in daily use and assessing the grounds of poor asthma and COPD control. How does inhaler switch affect patient satisfaction and disease control in real-world clinical practice? Explore the real-world results.

Insights
da
Challenging inhaler performance with simulated real-world conditions

Challenging inhaler performance with simulated real-world conditions

It is essential that an inhaler maintains its performance even when exposed to environmental stress conditions such as varying temperature, humidity and dropping. Read about the performance of Orion’s DPI under simulated real-world conditions.

Insights
nl-BE
Addressing pharmacokinetic bioequivalence of combination therapy – comparison of different dry powder inhalers

Addressing pharmacokinetic bioequivalence of combination therapy – comparison of different dry powder inhalers

Pharmacokinetic measures of lung deposition and systemic exposure of medication can help to evaluate and compare the efficacy and safety of inhaled therapy with different inhalers. Read more about pharmacokinetic bioequivalence study of Orion’s DPI and the originator product.

Insights
fi
Potilaiden tyytyväisyys inhalaattoriin on yhteydessä parempaan hoitomyöntyvyyteen ja astman hoitotasapainoon

Potilaiden tyytyväisyys inhalaattoriin on yhteydessä parempaan hoitomyöntyvyyteen ja astman hoitotasapainoon

Tutkimuksen mukaan kuivajauheinhalaattoria käyttävät potilaat olivat huomattavasti tyytyväisempiä hoitoonsa kuin ponnekaasuaerosolia käyttävät potilaat.

Corona
de
www.wehale.life/de/Corona/

www.wehale.life/de/Corona/

Informationen zum umgang mit asthma und COPD in coronazeiten


Wehale.life content for healthcare professionals is available for prescribing doctors in the following countries:

CLICK YOUR COUNTRY TO LOG IN

Belgium Belgium - French - Dutch
 
Denmark Denmark
 
Germany Germany
 
Finland Finland
 
Poland Poland
 
Spain Spain
 
Sweden Sweden
 
United Kingdom United Kingdom

Orion Corporation | Orionintie 1A, FI-02200 Espoo, Finland | Tel. +358 10 4261
Wehale.Life Contact us Orion Corporation 2020